Literature DB >> 17517868

Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

F Janaina Soares Rocha1, Ulrike Schleicher, Jochen Mattner, Gottfried Alber, Christian Bogdan.   

Abstract

Cutaneous leishmaniasis is caused by protozoan parasites of the genus Leishmania. The mechanisms of pathogen control have been established primarily in the mouse model of Leishmania major infection, but they might not hold true for other Leishmania species associated with cutaneous disease. Here, we analyzed the role of cytokines, signaling components, and effector molecules in the control of New World cutaneous leishmaniasis due to L. braziliensis. Unlike L. major, L. braziliensis caused small, nonulcerative, and self-healing skin swelling in C57BL/6 mice, as well as BALB/c mice. In contrast to the results obtained for L. mexicana, mice deficient for interleukin-12 or its key signaling molecule, signal transducer and activator of transcription 4, rapidly succumbed to severe visceral leishmaniasis. Infection of tumor necrosis factor knockout mice with L. braziliensis led to progressive, nonhealing skin lesions with erosions and hemorrhagic ulcerations, but in contrast to the results with L. major, only 20 to 30% of the mice developed fatal visceral disease. As seen with L. major, mice with a deleted inducible nitric oxide synthase gene (iNOS(-/-)) were unable to contain L. braziliensis in the skin, whereas the control of the parasite in the spleen remained unimpaired. Unlike what happens in L. major infections, NADPH oxidase had no impact on the course of disease in L. braziliensis-infected mice. These results not only define essential components of a protective immune response to L. braziliensis but also illustrate that the requirements for the control of cutaneous leishmaniasis vary between different parasite species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517868      PMCID: PMC1951993          DOI: 10.1128/IAI.01335-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  68 in total

Review 1.  The host response to Leishmania infection.

Authors:  W Solbach; T Laskay
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

Review 2.  Clinical spectrum of Leishmaniasis.

Authors:  R D Pearson; A Q Sousa
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

3.  Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.

Authors:  P Wilhelm; U Ritter; S Labbow; N Donhauser; M Röllinghoff; C Bogdan; H Körner
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

Authors:  F Mattner; J Magram; J Ferrante; P Launois; K Di Padova; R Behin; M K Gately; J A Louis; G Alber
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

5.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.

Authors:  M H Kaplan; Y L Sun; T Hoey; M J Grusby
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

6.  Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

Authors:  J G Howard; S Nicklin; C Hale; F Y Liew
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

7.  Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica.

Authors:  G E Childs; L K Lightner; L McKinney; M G Groves; E E Price; L D Hendricks
Journal:  Ann Trop Med Parasitol       Date:  1984-02

8.  A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases.

Authors:  R A Neal; C Hale
Journal:  Parasitology       Date:  1983-08       Impact factor: 3.234

9.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.

Authors:  R G Titus; M Marchand; T Boon; J A Louis
Journal:  Parasite Immunol       Date:  1985-09       Impact factor: 2.280

10.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  34 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.

Authors:  Eduardo Seiji Yamamoto; Bruno Luiz S Campos; Márcia Dalastra Laurenti; João H G Lago; Simone dos Santos Grecco; Carlos E P Corbett; Luiz Felipe D Passero
Journal:  Parasitol Res       Date:  2013-10-31       Impact factor: 2.289

4.  Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.

Authors:  Fernanda O Novais; Ba T Nguyen; Daniel P Beiting; Lucas P Carvalho; Nelson D Glennie; Sara Passos; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

5.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

6.  Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis.

Authors:  Diego L Costa; Tiago M Cardoso; Adriano Queiroz; Cristiane M Milanezi; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

7.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

8.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice.

Authors:  Diego A Vargas-Inchaustegui; Wendy Tai; Lijun Xin; Alison E Hogg; David B Corry; Lynn Soong
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

Review 10.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.